Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
26 August 2024, Israel: Evogene Ltd. (“Evogene” or the “Company”) (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize
Read More